Filing Details
- Accession Number:
- 0001493152-24-037965
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 16:30:06
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 16:30:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1708599 | Serina Therapeutics Inc. | SER | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1329505 | Gregory Bailey | 601 Genome Way, Suite 2001 Huntsville AL 35806 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-20 | 1,137 | $6.03 | 63,377 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reflects the weighted average purchase price of multiple transactions ranging from a low of $5.74 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Billionaire Hedge Funds
